|
Most drug testing methods involve
analyzing urine specimens. This process is known as urinalysis. Test results are
reported as "positive" or "negative" for illicit drugs. A positive test means
the drug has been used in the recent past, usually a period of days. Urinalysis
tests cannot determine if a particular individual is "impaired" by the drug
level found or when an employee last used a drug.
"Impaired" in this context is a legal
term: Having a level of drugs or alcohol during testing that is higher than a
prescribed "cut-off" limit (or level).
Testing is a two-stage
process.
First, an initial, or screening
test is administered. This type of screening is called Immunoassay or
Enzyme Multiplied Immunoassay Technique (EMIT). This is the most common type
of screening. Because it is particularly suitable for testing a large volume of
specimens, EMIT is the most widely used initial screening method.
If a test using the EMIT method is
positive for one or more drugs, then a second, confirmatory test is performed
for each identified drug. The confirmation test uses a different, more
sophisticated chemical process. It ensures that substances such as
over-the-counter medicines are not reported as positive. This confirmatory
testing method is called Gas Chromatography/Mass Spectrometry (GC/MS). GC/MS is
perhaps the most sensitive and accurate test yet developed. It requires an
extremely expensive test machine, as well as a highly trained technician. For
these reasons, GC/MS is used most often for confirmatory testing.
If your drug testing program is
mandated by Department of Transportation (DOT), its regulations require that all
confirmation tests must be performed using GC/MS. As well as its high level of
accuracy, GC/MS is also the only testing method that provides a documented data
record suitable for review and interpretation by an outside expert, such as a
Medical Review officer (MRO).
Process of Collecting
Specimen
The urine specimen is given at a
collection site, which is usually a clinic or doctor's office. We have
established relationships with extensive collection site facilities.
At the collection site, an employee
usually provides the specimen in private. A person who is trained in the
collection process seals and labels the specimen, then prepares both the
specimen and its accompanying paperwork for shipment to a drug testing
laboratory. Each step of the process is documented on a "chain of custody" form.
The collection and chain of custody procedures ensure the specimen is properly
identified and tracked throughout the testing process.
For companies that have to comply
with Department of Transportation (DOT) regulations, there is an additional
step. The urine sample must be split in two and put into primary and secondary
specimen bottles. This procedure is referred to as a "split specimen" procedure.
In a split specimen procedure, both
bottles are sent to the laboratory, but only the primary specimen is opened and
used for the initial screening and confirmatory tests. The secondary specimen
bottle remains sealed and stored at the laboratory.
If the confirmation test on the
primary specimen is positive, the employee has 72 hours to request that the
split specimen be sent to another certified laboratory for analysis. The split
specimen procedure essentially gives employees an opportunity for a "second
opinion" if their drug tests come out positive.
|